Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KRTX

Karuna Therapeutics (KRTX) Stock Price, News & Analysis

Karuna Therapeutics logo

About Karuna Therapeutics Stock (NASDAQ:KRTX)

Advanced Chart

Key Stats

Today's Range
$329.83
$329.83
50-Day Range
$313.97
$329.83
52-Week Range
$158.38
$329.99
Volume
5 shs
Average Volume
832,048 shs
Market Capitalization
$12.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Karuna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

KRTX Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Bristol Myers to Purchase Karuna
See More Headlines

KRTX Stock Analysis - Frequently Asked Questions

Karuna Therapeutics, Inc. (NASDAQ:KRTX) announced its quarterly earnings data on Thursday, February, 22nd. The company reported ($3.01) earnings per share for the quarter, missing the consensus estimate of ($2.65) by $0.36. Karuna Therapeutics's quarterly revenue was down 100.0% compared to the same quarter last year.

Karuna Therapeutics (KRTX) raised $70 million in an initial public offering on Friday, June 28th 2019. The company issued 4,400,000 shares at $15.00-$17.00 per share. Goldman Sachs, Citigroup and Wells Fargo Securities served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Karuna Therapeutics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Palo Alto Networks (PANW), Salesforce (CRM) and Netflix (NFLX).

Company Calendar

Last Earnings
2/22/2024
Today
7/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:KRTX
CIK
1771917
Fax
N/A
Employees
339
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$433.68 million
Pretax Margin
-66,209.48%

Debt

Sales & Book Value

Annual Sales
$654 thousand
Price / Sales
19,239.07
Price / Cash Flow
N/A
Book Value
$33.24 per share
Price / Book
9.92

Miscellaneous

Free Float
33,157,000
Market Cap
$12.58 billion
Optionable
Optionable
Beta
1.18
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:KRTX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners